Smith & Nephew (LON:SN)‘s stock had its “hold” rating reaffirmed by investment analysts at Deutsche Bank in a note issued to investors on Friday, ThisIsMoney.Co.Uk reports.
Other analysts also recently issued research reports about the stock. Shore Capital downgraded shares of Smith & Nephew to a “sell” rating in a report on Monday, June 10th. JPMorgan Chase & Co. downgraded shares of Aeroports de Paris from an “overweight” rating to a “neutral” rating in a report on Thursday, May 9th. Berenberg Bank reaffirmed a “hold” rating and set a GBX 900 ($11.76) price target on shares of WPP in a report on Friday, April 26th. Credit Suisse Group reaffirmed a “hold” rating and set a $32.00 price target on shares of CRH in a report on Thursday, April 25th. Finally, UBS Group upped their price target on shares of Tableau Software to $134.00 and gave the stock a “neutral” rating in a report on Thursday, May 2nd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 1,506.50 ($19.69).
Shares of Smith & Nephew stock opened at GBX 1,729 ($22.59) on Friday. The stock’s 50 day moving average price is GBX 1,699.61. Smith & Nephew has a 1-year low of GBX 1,242.50 ($16.24) and a 1-year high of GBX 1,767 ($23.09). The company has a debt-to-equity ratio of 30.12, a quick ratio of 1.08 and a current ratio of 2.10. The company has a market cap of $15.12 billion and a P/E ratio of 22.84.
In related news, insider Roland Diggelmann acquired 1,540 shares of the company’s stock in a transaction that occurred on Friday, May 3rd. The stock was acquired at an average price of GBX 1,532 ($20.02) per share, with a total value of £23,592.80 ($30,828.17).
About Smith & Nephew
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
See Also: What is a capital gains distribution?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.